JP2025510684A - マイコプラズマ・ガリセプティカム生ワクチン - Google Patents

マイコプラズマ・ガリセプティカム生ワクチン Download PDF

Info

Publication number
JP2025510684A
JP2025510684A JP2024555925A JP2024555925A JP2025510684A JP 2025510684 A JP2025510684 A JP 2025510684A JP 2024555925 A JP2024555925 A JP 2024555925A JP 2024555925 A JP2024555925 A JP 2024555925A JP 2025510684 A JP2025510684 A JP 2025510684A
Authority
JP
Japan
Prior art keywords
mycoplasma gallisepticum
vaccine
strain
composition
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024555925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510684A5 (https=
Inventor
エム． ファーガソン－ノエル，ナオラ
Original Assignee
ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド filed Critical ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド
Publication of JP2025510684A publication Critical patent/JP2025510684A/ja
Publication of JP2025510684A5 publication Critical patent/JP2025510684A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2024555925A 2022-04-06 2023-04-05 マイコプラズマ・ガリセプティカム生ワクチン Pending JP2025510684A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263327851P 2022-04-06 2022-04-06
US63/327,851 2022-04-06
US202263404226P 2022-09-07 2022-09-07
US63/404,226 2022-09-07
PCT/US2023/017527 WO2023196374A1 (en) 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines

Publications (2)

Publication Number Publication Date
JP2025510684A true JP2025510684A (ja) 2025-04-15
JP2025510684A5 JP2025510684A5 (https=) 2026-04-10

Family

ID=88243428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555925A Pending JP2025510684A (ja) 2022-04-06 2023-04-05 マイコプラズマ・ガリセプティカム生ワクチン

Country Status (7)

Country Link
US (1) US20250235521A1 (https=)
EP (1) EP4504902A4 (https=)
JP (1) JP2025510684A (https=)
CN (1) CN119816588A (https=)
AU (1) AU2023249151A1 (https=)
MX (1) MX2024011270A (https=)
WO (1) WO2023196374A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117434281B (zh) * 2023-10-18 2026-01-06 上海太阳生物技术有限公司 组合物、检测试剂、检测试剂盒以及在制备检测凝血因子x活性中的应用
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用
CN117965308B (zh) * 2024-03-07 2024-09-13 佛山科学技术学院 一种鹅源鸡毒支原体及其分离、鉴定方法和应用
CN119552994B (zh) * 2025-01-17 2025-11-14 广西壮族自治区动物疫病预防控制中心(广西壮族自治区屠宰技术中心) 鉴别鸡毒支原体野毒株和疫苗株的四重荧光pcr引物探针组合、反应体系、方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens

Also Published As

Publication number Publication date
US20250235521A1 (en) 2025-07-24
WO2023196374A1 (en) 2023-10-12
EP4504902A4 (en) 2026-05-06
EP4504902A1 (en) 2025-02-12
AU2023249151A1 (en) 2024-09-19
MX2024011270A (es) 2024-09-25
CN119816588A (zh) 2025-04-11

Similar Documents

Publication Publication Date Title
Ley et al. Mycoplasma gallisepticum infection
JP2025510684A (ja) マイコプラズマ・ガリセプティカム生ワクチン
JP5789897B2 (ja) マイコプラズマ・ボビス ワクチン
JP2013223511A6 (ja) マイコプラズマ・ボビス ワクチン
KR20120016282A (ko) 마이코플라스마　하이오뉴모니에의 온도 감수성 백신 균주 및 그의 용도
US8668912B2 (en) Mycoplasma gallisepticum formulation
UA121097C2 (uk) Імуногенна композиція, що містить антигени мікоплазм
US7217420B2 (en) Mycoplasma gallisepticum formulation
US8563005B2 (en) Actinobacillus suis antigens
US20250186512A1 (en) Live mycoplasma synoviae vaccine
KR20220110785A (ko) 애비박테리움 파라갈리나룸 및 조류 뇌척수염 바이러스 및 계두 바이러스에 대한 삼중 백신
Behboudi Turkey Rhinotracheitis
HK1161289B (en) Mycoplasma gallisepticum formulation
MATHEWS ASSESSMENT OF IMMUNOGENIC POTENCY OF INACTIVATED VACCINE AGAINST RIEMERELLOSIS IN BREEDER DUCKS
Hafez Respiratory diseases of turkeys–part one

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20250116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260402

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260402